Tom 20, Nr 3 (2023)
Artykuł przeglądowy
Opublikowany online: 2023-11-21
Pobierz cytowanie

Capgras syndrome in Parkinson’s disease — literature review

Monika Nowak1
·
Psychiatria 2023;20(3):131-134.
Afiliacje
  1. Wydział lekarski, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

dostęp płatny

Tom 20, Nr 3 (2023)
Artykuły przeglądowe
Opublikowany online: 2023-11-21

Streszczenie

Capgras syndrome (CS) can occur in the course of neurodegenerative diseases such as Parkinson’s disease (PD). CS is characterized by a delusional belief that people around patients have been replaced by imposters. The aim of this paper is to review current studies on the cases of patients with CS as a result of PD. Also, the proposition of treatment is included. A PubMed search was conducted using the keywords “Capgras syndrome”. “Parkinson’s disease”, “Dementia with Lewy Bodies” and “Misidentification Syndrome”. The search results were confined to articles written in English. Criteria for publications included the number of the patients who formed the study group; however, case reports are also included. In addition, publications had to contain information on the treatment of patients with CS. Numerous studies show the impact of PD on the development of CS. All patients with CS in PD were on levodopa, and some were also taking other dopaminergic drugs. CS can be a rare psychiatric manifestation of PD. Patients with advanced PD are more likely to develop delusions probably because of the long-term use of levodopa. Duplication is an example of delusional misidentification. There is no specific treatment; however, antipsychotic medication and changing the dose of dopaminergic drugs may reduce psychotic symptoms in patients with Parkinson’s disease psychosis.

Streszczenie

Capgras syndrome (CS) can occur in the course of neurodegenerative diseases such as Parkinson’s disease (PD). CS is characterized by a delusional belief that people around patients have been replaced by imposters. The aim of this paper is to review current studies on the cases of patients with CS as a result of PD. Also, the proposition of treatment is included. A PubMed search was conducted using the keywords “Capgras syndrome”. “Parkinson’s disease”, “Dementia with Lewy Bodies” and “Misidentification Syndrome”. The search results were confined to articles written in English. Criteria for publications included the number of the patients who formed the study group; however, case reports are also included. In addition, publications had to contain information on the treatment of patients with CS. Numerous studies show the impact of PD on the development of CS. All patients with CS in PD were on levodopa, and some were also taking other dopaminergic drugs. CS can be a rare psychiatric manifestation of PD. Patients with advanced PD are more likely to develop delusions probably because of the long-term use of levodopa. Duplication is an example of delusional misidentification. There is no specific treatment; however, antipsychotic medication and changing the dose of dopaminergic drugs may reduce psychotic symptoms in patients with Parkinson’s disease psychosis.
Pobierz cytowanie

Słowa kluczowe

Capgras syndrome; Parkinson’s disease; delusion

Informacje o artykule
Tytuł

Capgras syndrome in Parkinson’s disease — literature review

Czasopismo

Psychiatria

Numer

Tom 20, Nr 3 (2023)

Typ artykułu

Artykuł przeglądowy

Strony

131-134

Opublikowany online

2023-11-21

Wyświetlenia strony

475

Wyświetlenia/pobrania artykułu

46

DOI

10.5603/psych.96923

Rekord bibliograficzny

Psychiatria 2023;20(3):131-134.

Słowa kluczowe

Capgras syndrome
Parkinson’s disease
delusion

Autorzy

Monika Nowak

Referencje (20)
  1. DeMaagd G, Philip A. Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. P T. 2015; 40(8): 504–532.
  2. Mhyre TR, Boyd JT, Hamill RW, et al. Parkinson's disease. Subcell Biochem. 2012; 65: 389–455.
  3. Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007; 22(8): 1061–1068.
  4. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord. 2009; 24(15): 2175–2186.
  5. Hermanowicz N. Delusional misidentification in Parkinson's disease: report of two cases and a review. Postgrad Med. 2018; 130(2): 280–283.
  6. Josephs KA. Capgras syndrome and its relationship to neurodegenerative disease. Arch Neurol. 2007; 64(12): 1762–1766.
  7. Ellis HD, Lewis MB. Capgras delusion: a window on face recognition. Trends Cogn Sci. 2001; 5(4): 149–156.
  8. Cannas A, Meloni M, Mascia MM, et al. Capgras syndrome in Parkinson's disease: two new cases and literature review. Neurol Sci. 2017; 38(2): 225–231.
  9. Ostergaard PK. Capgras syndrome in senile dementia of the Alzheimer type. J Am Geriatr Soc. 1985; 33(11): 811.
  10. Roane DM, Rogers JD, Robinson JH, et al. Delusional misidentification in association with parkinsonism. J Neuropsychiatry Clin Neurosci. 1998; 10(2): 194–198.
  11. Soares HR, Cavalcante WC, Martins SN, et al. Capgras syndrome associated with limbic encephalitis in a patient with diffuse large B-cell lymphoma. Dement Neuropsychol. 2016; 10(1): 63–69.
  12. Shiotsuki H, Motoi Y, Nakamura SI, et al. Dopamine deficiency may lead to capgras syndrome in Parkinson's disease with dementia. J Neuropsychiatry Clin Neurosci. 2010; 22(3): 352i.e14–3352.e15.
  13. Miwa H, Mizuno Y. Capgras syndrome in Parkinson's disease. J Neurol. 2001; 248(9): 804–805.
  14. Groth CL, Pusso A, Sperling SA, et al. Capgras syndrome in advanced Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2018; 30(2): 160–163.
  15. Apaydin H, Benbir G. Capgras syndrome during the course of Parkinson disease dementia. J Neuropsychiatry Clin Neurosci. 2014; 26(3): E46.
  16. Kaufman KR, Newman NB, Dawood A. Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review. Ann Clin Psychiatry. 2014; 26(3): 187–191.
  17. Shah K, Jain SB, Wadhwa R. Capgras Syndrome. StatPearls [Internet], Treasure Island 2023.
  18. Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry. 1978; 135(6): 669–675.
  19. Pagonabarraga J, Llebaria G, García-Sánchez C, et al. A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia. Mov Disord. 2008; 23(3): 443–448.
  20. Kyrtsos CR, Stahl MC, Eslinger P, et al. Capgras syndrome in a patient with Parkinson's disease after bilateral subthalamic nucleus deep brain stimulation: a case report. Case Rep Neurol. 2015; 7(2): 127–133.

Regulamin

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest VM Media Group sp z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl